2019-24263. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for Start Printed Page 60094each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

    Table 1—List of Information Collections Approved By OMB

    Title of CollectionOMB control No.Date approval expires
    Agreement for Shipment of Devices for Sterilization0910-01319/30/2022
    Substances Prohibited from Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed0910-03399/30/2022
    Clinical Laboratory Improvement Amendments Waiver Applications0910-05989/30/2022
    Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments and Listing of Ingredients in Tobacco Products0910-06509/30/2022
    Tobacco Health Document Submission0910-06549/30/2022
    Guidance for Industry and Food and Drug Administration Staff; Section 905(j) Reports: Demonstrating Substantial Equivalence Requirements for Tobacco Products0910-06739/30/2022
    Exemptions From Substantial Equivalence Requirements for Tobacco Products0910-06849/30/2022
    Evaluation of the Program for Enhanced Review Transparency and Communication for New Molecular Entity New Drug Applications and Original Biologics License Applications in Prescription Drug User Fee Acts and 351(k) Biologics License Applications in Biosimilars User Fee Act0910-07469/30/2022
    Medical Device Accessories0910-08239/30/2022
    Start Signature

    Dated: October 29, 2019.

    Lowell J. Schiller,

    Principal Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2019-24263 Filed 11-6-19; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Published:
11/07/2019
Department:
Health and Human Services Department
Agency:
Food and Drug Administration
EntryType:
Notice
Action:
Notice.
Document Number:
2019-24263
Pages:
60093-60094 (2 pages)
Docket Numbers:
Docket Nos. FDA-2013-N-0375, FDA-2013-N-0520, FDA-2008-D-0031, FDA-2012-N-0386, FDA-2013-N-0377, FDA-2011-D-0147, FDA-2013-N-1588, FDA-2013-N-0093, and FDA-2016-N-1593
SectionNoes:
PDF File:
2019-24263.pdf